MedPage Today on MSN
Regimen improves PFS in highly mutated metastatic colorectal cancer
Accrual in this trial was suspended in March 2025 as a result of findings from the Checkmate 8HW trial, which showed that the ...
Colon cancer treatment is personalized based on stage, overall health and tumor characteristics. Early detection and accurate ...
Adding chemotherapy and bevacizumab to immunotherapy improves tumor control in a high-risk CRC subset, but this benefit comes ...
In BREAKWATER, EC plus FOLFIRI achieved a 64.4% response rate and showed a trend toward improved overall survival in patients ...
Pfizer Inc. (NYSE: PFE) today announced positive results from Cohort 3, a separate randomized cohort of the pivotal ...
According to Pfizer Inc. (NYSE:PFE), the BREAKWATER study shows statistically significant and clinically meaningful results, ...
MedPage Today on MSN
Targeted Duo Wins Again in BRAF-Mutant Colorectal Cancer
SAN FRANCISCO -- Including encorafenib (Braftovi) and cetuximab (Erbitux) in the first-line treatment of BRAF V600E-mutated ...
J&J shares positive long-term results of Rybrevant study for RAS/BRAF wild-type metastatic colorectal cancer at ASCO ...
Those with metastatic cancer may fare as well or better with chemotherapy alone. ORLANDO, Fla., May 30, 2009— -- Surgeons who plan to operate to remove the original tumors from patients with ...
A man was given two years to live after a colon cancer diagnosis. Now he's healthy thanks to combination of medicine and the ...
Yuman Fong, MD, discusses the evolution of colorectal liver metastases management from historical neglect to multimodal ...
Decluttering Mom on MSN
26-year-old thought it was hemorrhoids - diagnosis was stage 4 colon cancer
At 26, most people are juggling rent, careers, and group chats, not life-or-death medical decisions. So when a young woman ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback